Symptom check-ins during chemotherapy for pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether regularly reporting your symptoms to your care team during pre-surgery chemotherapy improves your experience and outcomes. The goal is to help manage side effects and support your treatment journey.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have pancreatic cancer that is still localized (not spread to other organs) and can potentially be removed with surgery.
- You are about to start chemotherapy (with or without radiation) before surgery, with the goal of curing your cancer.
- You will receive your treatment at an MD Anderson location in the Houston area.
- You can understand and communicate in English or Spanish.
- This is your first treatment for pancreatic cancer—you haven't had chemo or radiation for it before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study studies how a patient “reporting” program (called PRO) works for people with advanced pancreatic or bile-tract cancer. It may help teams understand symptoms and needs earlier to improve care and support during treatment.
This study looks at a scoring system to predict how well people with advanced pancreatic cancer might do after their first chemotherapy. If you have been diagnosed with this type of cancer and are about to start or have just finished your first treatment, this study may be able to use your health information to help guide future care.
This study checks if a simple blood test can find tiny bits of cancer DNA after your pancreatic surgery, which may help detect if cancer comes back earlier than scans. By joining, you'll help doctors learn how to better monitor the disease and guide future treatments.
This study offers a brief psychological intervention to help patients with pancreatic cancer manage emotional well-being before surgery. It is designed for newly diagnosed patients who are starting chemotherapy before surgery.
This study tests a personalized website program called COMPASS designed to help people with stage I-III pancreatic cancer improve their exercise and diet while receiving chemotherapy before surgery. The goal is to see if this program helps patients feel better and stay stronger during treatment.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
Hear when a new Neoadjuvant Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.